319 related articles for article (PubMed ID: 14744060)
1. First U.S.-Russian business venture in closed nuclear city.
Lopatto J; Wilkes B
Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
[No Abstract] [Full Text] [Related]
2. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
3. Benefits of biotech clusters questioned.
Sheridan C
Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
[No Abstract] [Full Text] [Related]
4. Chinese biotech: the need for innovation and higher standards.
Wong GH
Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
[No Abstract] [Full Text] [Related]
5. France to focus on a few biotech clusters.
Balcon E
Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
[No Abstract] [Full Text] [Related]
6. Biotechnology in South Africa.
Cloete TE; Nel LH; Theron J
Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
[TBL] [Abstract][Full Text] [Related]
7. Switzerland's medical technology potential.
Med Device Technol; 2004 Mar; 15(2):41-2. PubMed ID: 15154339
[TBL] [Abstract][Full Text] [Related]
8. International regional collaborations are paying off.
Mitchell P
Nat Biotechnol; 2004 Nov; 22(11):1475. PubMed ID: 15586420
[No Abstract] [Full Text] [Related]
9. The Netherlands innovation utilising.
Med Device Technol; 2008 Sep; 19(5):58-9. PubMed ID: 18947153
[No Abstract] [Full Text] [Related]
10. Germany biotech gets second chance.
Sheridan C
Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
[No Abstract] [Full Text] [Related]
11. France strives for sharper image.
Dalton R
Nature; 2007 Feb; 445(7129):699. PubMed ID: 17301763
[No Abstract] [Full Text] [Related]
12. The shape of European business in 2003.
Wagner M
Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
[No Abstract] [Full Text] [Related]
13. U.S and Russia agree to plan to shutdown three remaining Russian plutonium production reactors.
Health Phys; 2003 Jun; 84(6):792. PubMed ID: 12822592
[No Abstract] [Full Text] [Related]
14. New biotech oasis?
Sheridan C
Nat Biotechnol; 2005 Aug; 23(8):919. PubMed ID: 16114121
[No Abstract] [Full Text] [Related]
15. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
Rinaldi A
EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
[TBL] [Abstract][Full Text] [Related]
16. The benefits of design partnership.
Hogan J
Med Device Technol; 2005 May; 16(4):34-5. PubMed ID: 15941198
[TBL] [Abstract][Full Text] [Related]
17. Superscience me!
Nat Biotechnol; 2007 Jun; 25(6):604. PubMed ID: 17557082
[No Abstract] [Full Text] [Related]
18. Do governance, equity characteristics, and venture capital nvolvement affect long-term wealth creation in U.S. health care and biotechnology IPOs?
Williams DR; Duncan WJ; Ginter PM; Shewchuk RM
J Health Care Finance; 2006; 33(1):54-71. PubMed ID: 21110493
[TBL] [Abstract][Full Text] [Related]
19. FDA launches two research centers with academia.
Fox JL
Nat Biotechnol; 2014 Jul; 32(7):601. PubMed ID: 25004209
[No Abstract] [Full Text] [Related]
20. Increasing number of companies found ineligible for SBIR funding.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
